VYSCOXA Drug Patent Profile
Which patents cover Vyscoxa, and when can generic versions of Vyscoxa launch?
Vyscoxa is a drug marketed by Carwin Pharm Assoc and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VYSCOXA is celecoxib. There is one drug master file entry for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vyscoxa
A generic version of VYSCOXA was approved as celecoxib by TEVA on May 30th, 2014.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VYSCOXA?
- What are the global sales for VYSCOXA?
- What is Average Wholesale Price for VYSCOXA?
Summary for VYSCOXA
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in VYSCOXA? | VYSCOXA excipients list |
| DailyMed Link: | VYSCOXA at DailyMed |
Pharmacology for VYSCOXA
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for VYSCOXA
VYSCOXA is protected by one US patents.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carwin Pharm Assoc | VYSCOXA | celecoxib | SUSPENSION;ORAL | 211759-001 | Jul 29, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
